ReviewDrug design, development and therapy2026
Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Laurens A Van Kleef et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it